deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT04784416

Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)

Sponsor: Alzheimer's Association

Conditions Alzheimer Disease Mild Cognitive Impairment
Interventions 18F-MK-6240 Active tPBM-2.0 Sham tPBM-2.0
Updated 9 times since 2021 Last updated: Dec 2, 2025 Started: Apr 27, 2021 Primary completion: Oct 30, 2025 Completion: Jan 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Alzheimer Disease and Mild Cognitive Impairment, this trial is ongoing. The trial is conducted by Alzheimer's Association and has accumulated 9 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshotNot Yet Recruiting~Sep 2021 – ~Jul 2022 · 10 months · monthly snapshotRecruiting~Jul 2022 – ~May 2023 · 10 months · monthly snapshotRecruiting~May 2023 – ~Mar 2024 · 10 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotRecruiting~Feb 2025 – ~Jan 2026 · 11 months · monthly snapshotRecruiting~Jan 2026 – present · 6 months · monthly snapshotActive Not Recruiting

Change History

9 versions recorded

  1. Jan 2026 — Present [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Feb 2025 — Jan 2026 [monthly]

    Recruiting PHASE2

  3. Sep 2024 — Feb 2025 [monthly]

    Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  5. Mar 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

▶ Show 4 earlier versions

  1. May 2023 — Mar 2024 [monthly]

    Recruiting PHASE2

  2. Jul 2022 — May 2023 [monthly]

    Recruiting PHASE2

  3. Sep 2021 — Jul 2022 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  4. Apr 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alzheimer's Association
  • LiteCure LLC
  • NYU Langone Health
  • National Institutes of Health (NIH)
Data source: NYU Langone Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations